AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 24114400 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium citrate 1 g/day
Number of subjects: 1471
Study 24114400 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1471
Study 22377154 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracytoplasmic morphologically selected sperm injection (IMSI)
Number of subjects: 160
Study 22377154 — intervention group
Group type: COMPARATOR
Intervention: Intracytoplasmic sperm injection (ICSI)
Number of subjects: 160
Study 19363455 — intervention group
Group type: EXPERIMENTAL
Intervention: Fusion for nonradicular low back pain
Number of subjects: 0
Study 19363455 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard open discectomy and microdiscectomy for radiculopathy with herniated lumbar disc
Number of subjects: 0
Study 19363455 — intervention group
Group type: EXPERIMENTAL
Intervention: Decompressive surgery for symptomatic spinal stenosis
Number of subjects: 0
Study 19363455 — intervention group
Group type: COMPARATOR
Intervention: Artificial disc replacement for single level degenerative disc disease
Number of subjects: 0
Study 19363455 — intervention group
Group type: COMPARATOR
Intervention: Interspinous spacer device for 1- or 2-level spinal stenosis
Number of subjects: 0
Study 18265482 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat dietary intervention
Number of subjects: 2437
Study 15900109 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) treatment at dosages of 4 IU/m2/day, 6 IU/m2/day, or 8 IU/m2/day for a mean duration of 7.1 (0.4) years.
Number of subjects: 50
Study 12510062 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-stage bilateral Pemberton's pericapsular osteotomy with open reduction (group A1)
Number of subjects: 20
Study 12510062 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-stage bilateral Pemberton's pericapsular osteotomy without open reduction (group A2)
Number of subjects: 20
Study 12510062 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-stage bilateral Pemberton's pericapsular osteotomy (both groups A1 and A2)
Number of subjects: 20
Study 9659155 — intervention group
Group type: EXPERIMENTAL
Intervention: Alosetron (0.1, 0.5, 2.0 mg, twice daily)
Number of subjects: 27
Study 9659155 — intervention group
Group type: COMPARATOR
Intervention: Placebo (first week)
Number of subjects: 27
Study 8593549 — intervention group
Group type: EXPERIMENTAL
Intervention: Fortified milk (12 micrograms vitamin D3 and 1525 mg calcium per litre)
Number of subjects: 102
Study 8593549 — intervention group
Group type: COMPARATOR
Intervention: Unfortified milk (0.3 micrograms vitamin D3 and 1270 mg calcium per litre)
Number of subjects: 102
Study 2712625 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexible-ring annuloplasty
Number of subjects: 25
Study 2712625 — intervention group
Group type: COMPARATOR
Intervention: Rigid-ring annuloplasty
Number of subjects: 25
Study 337903 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral methoxsalen (0.6 mg/kg) and sunlight exposure
Number of subjects: 51
Study 337903 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral methoxsalen (0.3 mg/kg) and sunlight exposure
Number of subjects: 51
Study 337903 — intervention group
Group type: COMPARATOR
Intervention: Placebo prior to whole‐body exposure
Number of subjects: 51
Study 337903 — intervention group
Group type: COMPARATOR
Intervention: Sunlight exposure alone
Number of subjects: 51
Study 31266412 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive Patient Care Program (IPCP)
Number of subjects: 242
Study 31266412 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual education, cognitive rehabilitation training, and conventional treatment)
Number of subjects: 242
Study 28405780 — intervention group
Group type: EXPERIMENTAL
Intervention: Dysmenorrhea Daily Diary (DysDD)
Number of subjects: 355
Study 25943407 — intervention group
Group type: EXPERIMENTAL
Intervention: Hip extension strength training (n=9)
Number of subjects: 27
Study 25943407 — intervention group
Group type: EXPERIMENTAL
Intervention: Hip flexion strength training (n=9)
Number of subjects: 27
Study 25943407 — intervention group
Group type: COMPARATOR
Intervention: No intervention (n=9)
Number of subjects: 27
Study 23952600 — intervention group
Group type: EXPERIMENTAL
Intervention: Tirasemtiv
Number of subjects: 143
Study 21319378 — intervention group
Group type: EXPERIMENTAL
Intervention: ASA group
Number of subjects: 96
Study 21319378 — intervention group
Group type: EXPERIMENTAL
Intervention: WASCA group
Number of subjects: 96
Study 21319378 — intervention group
Group type: EXPERIMENTAL
Intervention: IR+WASCA group
Number of subjects: 96
Study 21319378 — intervention group
Group type: COMPARATOR
Intervention: All groups
Number of subjects: 96
Study 19100304 — intervention group
Group type: EXPERIMENTAL
Intervention: 7-valent conjugated pneumococcal vaccine (PCV7)
Number of subjects: 241
Study 19100304 — intervention group
Group type: COMPARATOR
Intervention: 23-valent polysaccharide vaccine (23vPPV)
Number of subjects: 241
Study 16885405 — intervention group
Group type: EXPERIMENTAL
Intervention: Adiponectin (mean +/- SD 12.8 +/- 8.0 mug/ml)
Number of subjects: 820
Study 16885405 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 820
Study 12527148 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmaceutical care program (group A)
Number of subjects: 21
Study 12527148 — intervention group
Group type: COMPARATOR
Intervention: Regular treatment without pharmaceutical intervention (group B)
Number of subjects: 21
Study 12527148 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (A and B)
Number of subjects: 21
Study 11200128 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrapericardial sclerotherapy with thiotepa
Number of subjects: 0
Study 11200128 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrapericardial sclerotherapy with tetracyclines
Number of subjects: 0
Study 11200128 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous echo‐guided pericardiocentesis
Number of subjects: 0
Study 11200128 — intervention group
Group type: EXPERIMENTAL
Intervention: Different agents for sclerosing or cytostatic activity (e.g., bleomycin, thiotepa, radionuclides)
Number of subjects: 0
Study 8792974 — intervention group
Group type: EXPERIMENTAL
Intervention: Free TRAM flap
Number of subjects: 43
Study 8792974 — intervention group
Group type: COMPARATOR
Intervention: Pedicled TRAM flap
Number of subjects: 43
Study 1739854 — intervention group
Group type: EXPERIMENTAL
Intervention: Memory remediation treatment (compensatory and executive training skills), delivered 6 hours weekly over a 2 1/2‐week period
Number of subjects: 12
Study 1739854 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 12
Study 6338715 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean red cell volume in alcoholic patients
Number of subjects: 625
Study 6338715 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean red cell hemoglobin in alcoholic patients
Number of subjects: 625
Study 6338715 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean red cell volume and mean red cell hemoglobin in patients with excessive alcohol consumption
Number of subjects: 625
Study 6338715 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean red cell volume and mean red cell hemoglobin in patients with decreased alcohol consumption
Number of subjects: 625
Study 6338715 — intervention group
Group type: EXPERIMENTAL
Intervention: Specificity of mean red cell volume
Number of subjects: 625
Study 6338715 — intervention group
Group type: EXPERIMENTAL
Intervention: Specificity of mean red cell hemoglobin
Number of subjects: 625
Study 30821056 — intervention group
Group type: EXPERIMENTAL
Intervention: Delta power (0.5-4.5 Hz) during non-rapid eye movement sleep
Number of subjects: 61
Study 30821056 — intervention group
Group type: EXPERIMENTAL
Intervention: Sigma power (12-15 Hz) during non-rapid eye movement sleep
Number of subjects: 61
Study 28558654 — intervention group
Group type: EXPERIMENTAL
Intervention: PPV group (n=84)
Number of subjects: 109
Study 28558654 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=84)
Number of subjects: 109
Study 27652199 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive SIJ fusion with triangular titanium implants (SIJF, n = 102)
Number of subjects: 148
Study 27652199 — intervention group
Group type: COMPARATOR
Intervention: Non-surgical management (NSM, n = 46)
Number of subjects: 148
Study 27652199 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive SIJ fusion with triangular titanium implants (SIJF)
Number of subjects: 148
Study 27652199 — intervention group
Group type: COMPARATOR
Intervention: Non-surgical management (NSM)
Number of subjects: 148
Study 24968990 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term humidification therapy (LTHT)
Number of subjects: 87
Study 24968990 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 87
Study 21623930 — intervention group
Group type: EXPERIMENTAL
Intervention: Twice weekly TC regimen
Number of subjects: 242
Study 21623930 — intervention group
Group type: EXPERIMENTAL
Intervention: Tapering TC regimen (3/week for 1st month, 2/week for 2nd month, 1/week for 4th month)
Number of subjects: 242
Study 21623930 — intervention group
Group type: COMPARATOR
Intervention: Both regimens (twice weekly and tapering)
Number of subjects: 242
Study 21623930 — intervention group
Group type: COMPARATOR
Intervention: Both regimens
Number of subjects: 242
Study 18953611 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative imatinib (600 mg daily for 3, 5, or 7 days)
Number of subjects: 19
Study 18953611 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative imatinib (for 2 years)
Number of subjects: 19
Study 18953611 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative imatinib
Number of subjects: 19
Study 18953611 — intervention group
Group type: COMPARATOR
Intervention: Imatinib (compared to imatinib-naïve historical control)
Number of subjects: 19
Study 17351024 — intervention group
Group type: EXPERIMENTAL
Intervention: Reiki
Number of subjects: 16
Study 17351024 — intervention group
Group type: COMPARATOR
Intervention: Rest
Number of subjects: 16
Study 14675236 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical resection and radiotherapy
Number of subjects: 0
Study 14675236 — intervention group
Group type: EXPERIMENTAL
Intervention: Intubation with a plastic prosthesis
Number of subjects: 0
Study 14675236 — intervention group
Group type: EXPERIMENTAL
Intervention: Stage-directed therapeutic plan
Number of subjects: 0
Study 12074620 — intervention group
Group type: EXPERIMENTAL
Intervention: Early active mobilization regimen (Group A)
Number of subjects: 36
Study 12074620 — intervention group
Group type: COMPARATOR
Intervention: Dynamic splintage regimen (Group B)
Number of subjects: 36
Study 12074620 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 36
Study 11696123 — intervention group
Group type: EXPERIMENTAL
Intervention: midazolam 0.5 mg.kg(‐1)
Number of subjects: 52
Study 11696123 — intervention group
Group type: COMPARATOR
Intervention: midazolam vehicle
Number of subjects: 52
Study 9312763 — intervention group
Group type: EXPERIMENTAL
Intervention: Lovastatin 20 mg/night
Number of subjects: 42
Study 9312763 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 42
Study 8213511 — intervention group
Group type: EXPERIMENTAL
Intervention: Felodipine
Number of subjects: 16
Study 8213511 — intervention group
Group type: COMPARATOR
Intervention: Hydrochlorothiazide
Number of subjects: 16
Study 3114964 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg Adriamycin once weekly for a period of 6 weeks
Number of subjects: 64
Study 3114964 — intervention group
Group type: COMPARATOR
Intervention: 50 mg Adriamycin once a month over a period of 2 years
Number of subjects: 64
Study 30672432 — intervention group
Group type: EXPERIMENTAL
Intervention: 75% field capacity irrigation treatment
Number of subjects: 3
Study 30672432 — intervention group
Group type: EXPERIMENTAL
Intervention: 50% field capacity irrigation treatment
Number of subjects: 3
Study 30672432 — intervention group
Group type: COMPARATOR
Intervention: Control (100% field capacity)
Number of subjects: 3
Study 30672432 — intervention group
Group type: EXPERIMENTAL
Intervention: Water stress (general)
Number of subjects: 3
Study 27399956 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05 mL injection volume of abobotulinumtoxinA (10 Speywood units)
Number of subjects: 0
Study 27399956 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1 mL injection volume of abobotulinumtoxinA (10 Speywood units)
Number of subjects: 0
Study 25407349 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical medication reviews (CMRs) facilitated by an expert team (GP and pharmacist)
Number of subjects: 500
Study 25407349 — intervention group
Group type: COMPARATOR
Intervention: Usual general practice care
Number of subjects: 500
Study 25407349 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical medication reviews (CMRs)
Number of subjects: 500
Study 23266112 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality circles implementation in the experimental group
Number of subjects: 2
Study 20034973 — intervention group
Group type: EXPERIMENTAL
Intervention: Persistent ST-segment depression (STD) at follow-up ECG
Number of subjects: 3877
Study 20034973 — intervention group
Group type: EXPERIMENTAL
Intervention: New ST-segment depression (STD) on follow-up ECG
Number of subjects: 3877
Study 20034973 — intervention group
Group type: EXPERIMENTAL
Intervention: Every 1 mm increment of STD on follow-up ECG
Number of subjects: 3877
Study 18403223 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed combination of ipratropium and albuterol (IB+ALB)
Number of subjects: 113
Study 18403223 — intervention group
Group type: COMPARATOR
Intervention: Albuterol alone (ALB)
Number of subjects: 113
Study 16687205 — intervention group
Group type: COMPARATOR
Intervention: Darifenacin 7.5mg od (weeks 1-2), 15mg od (week 3)
Number of subjects: 150
Study 16687205 — intervention group
Group type: COMPARATOR
Intervention: Oxybutynin ER 10mg od (increasing to 15mg od then 20mg od by week 3)
Number of subjects: 150
Study 16687205 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study 12939533 — intervention group
Group type: EXPERIMENTAL
Intervention: 25%O(2)
Number of subjects: 8
Study 12939533 — intervention group
Group type: EXPERIMENTAL
Intervention: 30%O(2)
Number of subjects: 8
Study 12939533 — intervention group
Group type: COMPARATOR
Intervention: Control (21% O2)
Number of subjects: 8
Study 10885682 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (10, 25, 20 mg doses)
Number of subjects: 115
Study 10885682 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy age-matched peers)
Number of subjects: 115
Study 10885682 — intervention group
Group type: EXPERIMENTAL
Intervention: ADHD only
Number of subjects: 115
Study 10885682 — intervention group
Group type: EXPERIMENTAL
Intervention: ADHD + RD
Number of subjects: 115
Study 10885682 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 115
Study 9289443 — intervention group
Group type: EXPERIMENTAL
Intervention: Kliogest hormone therapy
Number of subjects: 17
Study 1521669 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 mg/kg mexiletine
Number of subjects: 30
Study 1521669 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg/kg mexiletine
Number of subjects: 30
Study 1521669 — intervention group
Group type: COMPARATOR
Intervention: saline
Number of subjects: 30
Study 29218808 — intervention group
Group type: EXPERIMENTAL
Intervention: iPOPP intervention
Number of subjects: 150
Study 29218808 — intervention group
Group type: EXPERIMENTAL
Intervention: Pedometer plus usual care and written information
Number of subjects: 150
Study 29218808 — intervention group
Group type: COMPARATOR
Intervention: Usual care plus written information
Number of subjects: 150
Study 27475772 — intervention group
Group type: EXPERIMENTAL
Intervention: Social ecologically-based intervention (50-week exercise facilitator intervention with 8 telephone contacts: 3 individual and 5 group)
Number of subjects: 604
Study 27475772 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 604
Study 27475772 — intervention group
Group type: EXPERIMENTAL
Intervention: Social ecologically-based intervention
Number of subjects: 604
Study 24584926 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous abatacept (ABA) 125 mg/week
Number of subjects: 1134
Study 22918610 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose of 0.5 Gy
Number of subjects: 199
Study 22918610 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose of 1.0 Gy
Number of subjects: 199
Study 19907348 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture plus usual care
Number of subjects: 175
Study 19907348 — intervention group
Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 175
Study 18714228 — intervention group
Group type: EXPERIMENTAL
Intervention: Stable condition with a flat bench
Number of subjects: 20
Study 18714228 — intervention group
Group type: COMPARATOR
Intervention: Unstable condition with a Swiss ball
Number of subjects: 20
Study 16966588 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous Coronary Intervention (PCI)
Number of subjects: 445
Study 16966588 — intervention group
Group type: COMPARATOR
Intervention: Coronary Artery Bypass Grafting (CABG)
Number of subjects: 445
Study 14748460 — intervention group
Group type: EXPERIMENTAL
Intervention: Wet suit
Number of subjects: 12
Study 10866886 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.07 mg/kg morphine (M1)
Number of subjects: 8
Study 10866886 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.14 mg/kg morphine (M2)
Number of subjects: 8
Study 10866886 — intervention group
Group type: COMPARATOR
Intervention: 0.14 mg/kg oxycodone (O)
Number of subjects: 8
Study 10866886 — intervention group
Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 8
Study 9083824 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive outpatient treatment (INT)
Number of subjects: 0
Study 9083824 — intervention group
Group type: COMPARATOR
Intervention: Individual therapy (IND)
Number of subjects: 0
Study 9083824 — intervention group
Group type: COMPARATOR
Intervention: Individual plus group therapy (IND-GRP)
Number of subjects: 0
Study 8212201 — intervention group
Group type: EXPERIMENTAL
Intervention: Quadruple therapy (prophylactic antilymphoblast globulin - ALG)
Number of subjects: 121
Study 8212201 — intervention group
Group type: COMPARATOR
Intervention: Triple therapy (no prophylactic ALG)
Number of subjects: 121
Study 8212201 — intervention group
Group type: EXPERIMENTAL
Intervention: Quadruple therapy
Number of subjects: 121
Study 8212201 — intervention group
Group type: COMPARATOR
Intervention: Triple therapy
Number of subjects: 121
Study 8212201 — intervention group
Group type: COMPARATOR
Intervention: Immediate CsA group (triple therapy)
Number of subjects: 121
Study 3544690 — intervention group
Group type: EXPERIMENTAL
Intervention: Bendroflumethiazide 2.5‐5 mg/day
Number of subjects: 106
Study 3544690 — intervention group
Group type: COMPARATOR
Intervention: Propranolol 160‐320 mg daily
Number of subjects: 106
Study 29398422 — intervention group
Group type: EXPERIMENTAL
Intervention: Current users of hormone replacement therapy
Number of subjects: 75587
Study 29398422 — intervention group
Group type: COMPARATOR
Intervention: Never-users of hormone replacement therapy
Number of subjects: 75587
Study 27788847 — intervention group
Group type: EXPERIMENTAL
Intervention: Empirical electrical left atrial appendage isolation along with extensive ablation (group 1)
Number of subjects: 173
Study 27788847 — intervention group
Group type: COMPARATOR
Intervention: Extensive ablation alone (group 2)
Number of subjects: 173
Study 24635827 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus reuteri DSM 17938, 5 drops/daily (10^8 colony-forming units), for 4 weeks (n=20)
Number of subjects: 40
Study 24635827 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n=20)
Number of subjects: 40
Study 22410602 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy (CBT) intervention, 8 sessions from April 9 to May 28, 2009
Number of subjects: 32
Study 22410602 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 32
Study 21808448 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflurane
Number of subjects: 38
Study 21808448 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane
Number of subjects: 38
Study 18306334 — intervention group
Group type: EXPERIMENTAL
Intervention: Habitual Activity Estimation Scale (HAES)
Number of subjects: 14
Study 18306334 — intervention group
Group type: EXPERIMENTAL
Intervention: Validated 3-day activity diary
Number of subjects: 14
Study 18306334 — intervention group
Group type: EXPERIMENTAL
Intervention: ActiGraph Accelerometer
Number of subjects: 14
Study 18306334 — intervention group
Group type: EXPERIMENTAL
Intervention: HAES, diary, and accelerometer
Number of subjects: 14
Study 16053402 — intervention group
Group type: EXPERIMENTAL
Intervention: Nursing intervention group (n = 38)
Number of subjects: 75
Study 16053402 — intervention group
Group type: COMPARATOR
Intervention: Care as usual group (n = 37)
Number of subjects: 75
Study 16053402 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 75
Study 12450903 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose vitamin A supplements
Number of subjects: 0
Study 12450903 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 10071265 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy
Number of subjects: 192
Study 7731150 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant IFN alpha (subcutaneous injection three times a week for 12 months)
Number of subjects: 40
Study 7731150 — intervention group
Group type: COMPARATOR
Intervention: Supportive treatment only (Control)
Number of subjects: 40
Study 7731150 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant IFN alpha
Number of subjects: 40
Study 2046771 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroquinine (200 mg in the evening and 200 mg before going to bed)
Number of subjects: 59
Study 2046771 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study 6790884 — intervention group
Group type: EXPERIMENTAL
Intervention: Cream containing 2% coal tar, 1% diiodohydroxyquinolin, and 0.5% hydrocortisone applied 3 times a day for one month
Number of subjects: 29
Study 6790884 — intervention group
Group type: COMPARATOR
Intervention: Placebo applied on the contralateral region
Number of subjects: 29
Study 30806520 — intervention group
Group type: EXPERIMENTAL
Intervention: Secukinumab 150 mg
Number of subjects: 0